Cabot (NYSE:CBT) Updates FY25 Earnings Guidance

Cabot (NYSE:CBT) updated its FY25 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $7.40-7.80 for the period, compared to the consensus estimate of $7.85. Cabot also updated its FY 2025 guidance to 7.400-7.800 EPS.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on CBT shares. Mizuho increased their target price on Cabot from $103.00 to $122.00 and gave the company an “outperform” rating in a report on Tuesday. UBS Group cut their target price on shares of Cabot from $103.00 to $98.00 and set a “neutral” rating for the company in a research report on Tuesday, August 6th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Cabot from $95.00 to $105.00 and gave the company a “neutral” rating in a report on Wednesday, August 7th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, Cabot has an average rating of “Hold” and a consensus price target of $105.00.

Cabot Stock Down 1.8 %

CBT traded down $1.93 during midday trading on Tuesday, hitting $108.16. 365,728 shares of the company’s stock traded hands, compared to its average volume of 336,202. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.22 and a quick ratio of 1.45. The company has a market cap of $5.93 billion, a PE ratio of 12.87, a price-to-earnings-growth ratio of 0.91 and a beta of 1.20. The stock’s fifty day simple moving average is $108.30 and its 200-day simple moving average is $101.01. Cabot has a one year low of $66.02 and a one year high of $117.14.

Cabot (NYSE:CBT) last released its quarterly earnings results on Monday, November 4th. The specialty chemicals company reported $1.80 earnings per share for the quarter, missing analysts’ consensus estimates of $1.81 by ($0.01). The business had revenue of $1 billion for the quarter, compared to the consensus estimate of $1.01 billion. Cabot had a net margin of 12.05% and a return on equity of 26.99%. The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.65 EPS. As a group, equities analysts anticipate that Cabot will post 7.07 earnings per share for the current fiscal year.

Insider Activity at Cabot

In related news, CFO Erica Mclaughlin sold 23,274 shares of the company’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $99.79, for a total transaction of $2,322,512.46. Following the completion of the transaction, the chief financial officer now directly owns 59,814 shares in the company, valued at $5,968,839.06. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other Cabot news, CEO Sean D. Keohane sold 25,617 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total value of $2,601,406.35. Following the completion of the transaction, the chief executive officer now owns 331,174 shares of the company’s stock, valued at $33,630,719.70. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Erica Mclaughlin sold 23,274 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $99.79, for a total value of $2,322,512.46. Following the sale, the chief financial officer now owns 59,814 shares in the company, valued at approximately $5,968,839.06. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 71,939 shares of company stock worth $7,308,812 in the last 90 days. 3.07% of the stock is owned by company insiders.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.